Navigation Links
Champions Biotechnology Exercises Option to License Proprietary Compound Based on Successful Tumorgraft™ Test Results
Date:4/1/2011

BALTIMORE, Md., April 1, 2011 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC: CSBR) ("Champions" or "the Company") announced today that it has exercised an option to license Irinophore C™, a liposomal formulation of Irinotecan, from the BC Cancer Agency ("BCCA") in British Columbia, Canada. This action was the result of the positive results obtained from a Tumorgraft™ study done on Irinophore C™ utilizing Champions' proprietary technology platform.

Irinophore C™ is a lipid-based nanoparticle made by efficiently loading the irinotecan payload into its interior core using a novel and proprietary method. The compound is currently completing preclinical development and is due to enter phase I clinical study as a single agent in patients having advanced solid tumors in Q4 2011.  Champions tested the activity of Irinophore C™ using its Tumorgraft™ translational technology platform.  The results demonstrated significant efficacy and safety advantages in Irinophore C™ as compared to the approved drug Irinotecan (Camptosar) on various tumor types.

In February 2010, Champions entered into an exclusive option agreement with BCCA for the exclusive right to review Irinophore C™ for the treatment of various forms of solid tumor cancer. The exercise of the option will result in immediate costs to the Company of approximately $85,000 comprised of the option exercise price and reimbursement to BCCA for past patent costs. Champions is currently exploring strategic options for financing the clinical development costs of Irinophore C™.

The Company also announced that it will not pursue further any of the three compounds for which it signed licensing agreements. The Company's scientific advisory committee has reviewed the results of the Tumorgraft™ studies performed on each of these compounds and recommended that the Company stop investing resources in the development of these compoun
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Champions CFO Resigns
2. Champions Biotechnology Awarded $1.46 million in Grants
3. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
4. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
5. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
6. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
7. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
8. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
9. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
10. Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
11. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
(Date:4/21/2014)... consider ways to ease prohibitions on marijuana, the public ... the past century may provide valuable lessons, according to ... legalized marijuana in Colorado and Washington for recreational uses ... to best allow the production, sales and the use ... social ills. , A new study published online by ...
(Date:4/20/2014)... type of cell in the lining of the bladder ... according to researchers at the Stanford University School of ... first to pinpoint the normal cell type that can ... first to show that most bladder cancers and their ... explains why many human bladder cancers recur after therapy. ...
(Date:4/18/2014)... University School of Medicine researchers have been awarded two-year ... Novo Nordisk announced this month. Of the 110 initial ... Biologics Science Forum Program, only four projects were funded, ... They are Jonathan Powell, M.D., Ph.D.; G. William Wong, ... Powell, a professor of oncology, will use his $500,000 ...
(Date:4/18/2014)... available in French . ... practice and regenerative medicine. A team led by Ludwik ... Paris Tech) and Didier Letourneur from the Laboratoire Recherche ... just demonstrated that the principle of adhesion by aqueous ... repair soft-tissue organs and tissues. This easy-to-use gluing method ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
Breaking Medicine News(10 mins):Health News:Regulating legal marijuana could be guided by lessons from alcohol and tobacco, study says 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2
... Free Support Magazine Helps Individuals and Families Embrace Life to ... N.J., Dec. 5 ConvaTec, a world-leading developer and marketer ... today the launch of ConTact, the new global lifestyle magazine ... with practical advice and feature articles on living a healthy ...
... 5 Empire BlueCross BlueShield today,announced that its employees ... 2008 Associate Giving Campaign. This amount is the,result ... match from the,WellPoint Foundation, Inc. , ... and health services,organizations are especially in need of help," ...
... Call on BCBS and OPM to Restore 2008 Benefits, Extend "Open Season" ... , Affected Patients and Doctors Available to ... , WASHINGTON, Dec. 5 Tick, Tick, Tick! Nearly half ... 8th to either change health care plans or face some costly penalties ...
... SEYMOUR, Tenn., Dec. 5 For many, city ... The usual hustle and bustle is further,glamorized by ... crowds,eager to soak in the joyful atmosphere. However, ... can be an emotionally trying time,filled with expectations ...
... N.J., Dec. 5 World Gourmet Marketing, LLC, creator,of the ... healthier,snack alternatives at the concession stands of the IZOD CENTER. ... when obesity is a national concern, the Nets are recognizing ... offerings,include: World Gourmet,s Sensible Portions Multi Grain Crisps, which are,baked, ...
... 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life ... laboratory services, announced today that the Company will release ... on December 17, 2008, at approximately 5:00 p.m. (ET). ... which will be held on December 18, 2008, at ...
Cached Medicine News:Health News:ConvaTec Launches New Lifestyle Magazine for People With an Ostomy 2Health News:Empire BlueCross BlueShield Associates Commit Over $1 Million to Community Organizations in 2008 2Health News:Clock Ticking for Millions of Federal Employees Hoping to Avoid Blue Cross/Blue Shield Benefits Cut 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 3Health News:Nets Provide Fans with Healthy In-Game Snack Option 2Health News:DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast 2
Hydrophilic Acrylic Intraocular Lens, AC depth: 4.65....
The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
... The Bausch & Lomb SoFlex™ ... Lenses are intended to be ... the visual correction of aphakia ... age or older where a ...
Liberty Three Piece PMMA Lens with UV Absorber....
Medicine Products: